Frontiers in Pharmacology
- Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice11 hours ago
- Multi-target neuroprotective mechanisms of epigallocatechin-3-gallate (EGCG) in stroke: from molecular pathways to nanomedicine delivery and clinical translation13 hours ago
- Recent advances in research on novel therapeutic mechanisms and strategies for exosome-based treatment of ischemic stroke13 hours ago
- Systems-level analysis uncovers eight hub genes and a resveratrol-based therapeutic strategy for ischemic stroke17 hours ago
- Immune checkpoint inhibitor-related myotoxicity in lung cancer: a decade-long real-world pharmacovigilance analysis of the FAERS database17 hours ago
- Differential effects of nAChR modulators on impulsive action in a nicotine self-administration Go/No-Go task in rats2 days ago
- Icariside II protects against neuronal injury by modulating PI3K/AKT-dependent mitochondrial dynamics and apoptosis in Alzheimer’s disease models2 days ago
- Efficacy and safety of oxiracetam for cognitive and functional outcomes after acute traumatic brain injury in Chinese populations: a systematic review and meta-analysis of randomized controlled trials2 days ago
- Clinical research progress of esketamine in perioperative neuroprotection: from mechanisms to therapeutic neuroprotection5 days ago
- Early socially isolated rats of both sexes reduce alcohol consumption and seeking by the Galanin (1–15) and naltrexone combination5 days ago
- The effects of fentanyl and dexmedetomidine on cardiorespiratory activity: implications for morbidity and mortality associated with adulterated fentanyl products6 days ago
- 2′-deoxyinosine ameliorates multiple sclerosis through modulating Th1/Th2 and Th17/Treg cell balance with potential involvement of AMPK phosphorylation6 days ago
- Systematic review and meta-analysis of the antidepressant-like effects of ginsenosides in animal models: comparative behavioral profiles and exploratory dose-stratified analysis6 days ago
- Catechins in stroke: multi-target mechanisms, preclinical evidence, and translational challenges6 days ago
- Blarcamesine improves EEG biomarkers of cortical dysfunction in a mouse model of fragile X syndrome7 days ago